LLY

993.35

+1.19%↑

JNJ

206.6

+3.36%↑

ABBV

225.03

+1%↑

UNH

327.77

+1.31%↑

AZN

91.43

+2.09%↑

LLY

993.35

+1.19%↑

JNJ

206.6

+3.36%↑

ABBV

225.03

+1%↑

UNH

327.77

+1.31%↑

AZN

91.43

+2.09%↑

LLY

993.35

+1.19%↑

JNJ

206.6

+3.36%↑

ABBV

225.03

+1%↑

UNH

327.77

+1.31%↑

AZN

91.43

+2.09%↑

LLY

993.35

+1.19%↑

JNJ

206.6

+3.36%↑

ABBV

225.03

+1%↑

UNH

327.77

+1.31%↑

AZN

91.43

+2.09%↑

LLY

993.35

+1.19%↑

JNJ

206.6

+3.36%↑

ABBV

225.03

+1%↑

UNH

327.77

+1.31%↑

AZN

91.43

+2.09%↑

Home・Akcijų sąrašas・Pulse Biosciences Inc

Pulse Biosciences Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

14.16 2.83

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

13.61

Max

13.89

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-217K -19M
Pardavimai	86K 86K
Pelnas, tenkantis vienai akcijai	-0.29
Pelno marža	-22,540.698
Darbuotojai	75
EBITDA	-228K -19M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+63.08% upside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-179M 958M
Ankstesnė atidarymo kaina	11.33
Ankstesnė uždarymo kaina	14.16

Naujienos nuotaikos

By Acuity

37%

63%

134 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

16.59 / 17.17 Palaikymas ir pasipriešinimas

Pulse Biosciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-09 22:13; UTC

Uždarbis

GE Vernova Raises Outlook, Doubles Dividend on Energy Market Momentum

2025-12-09 21:40; UTC

Uždarbis

GameStop Sales Fall as Collectibles Remain Only Bright Spot

2025-12-09 18:51; UTC

Įsigijimai, susijungimai, perėmimai

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

2025-12-09 16:57; UTC

Pagrindinės rinkos jėgos

Clear Secure Rises on Medicare Identity Verification Contract

2025-12-09 23:46; UTC

Rinkos pokalbiai

Nikkei May Trade Rangebound Ahead of Fed Rate Decision -- Market Talk

2025-12-09 23:46; UTC

Įsigijimai, susijungimai, perėmimai

Legend Holdings Stake in Lenovo Now at 32.34%

2025-12-09 23:45; UTC

Įsigijimai, susijungimai, perėmimai

Legend Holdings: Remains Optimistic About Lenovo's Future Development Potential

2025-12-09 23:44; UTC

Įsigijimai, susijungimai, perėmimai

Legend Holdings: Purchased Lenovo Shares at Average Price of HK$9.7653/Share

2025-12-09 23:43; UTC

Įsigijimai, susijungimai, perėmimai

Legend Holdings: Acquired Lenovo Shares for Total Cash Consideration of HK$1.12B

2025-12-09 23:43; UTC

Įsigijimai, susijungimai, perėmimai

Legend Holdings: Acquired 115.17M Lenovo Shares From Open Market Between Nov. 21 and Dec. 9

2025-12-09 23:35; UTC

Rinkos pokalbiai

Gold Edges Higher Ahead of FOMC Decision -- Market Talk

2025-12-09 22:42; UTC

Uždarbis

PepsiCo Wants to Boost Sales, Cut Costs. The Street Is Doubtful. -- Barrons.com

2025-12-09 21:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2025-12-09 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-09 21:48; UTC

Rinkos pokalbiai

Hiring Confidence Slips in Canada Entering 2026 -- Market Talk

2025-12-09 21:36; UTC

Uždarbis

Casey's General Stores: Fiscal 2026 EBITDA Is Expected to Increase 15% to 17% >CASY

2025-12-09 21:36; UTC

Uždarbis

Casey's General Stores: Total Inside Gross Profit Increased 13.5% to $703.4M Compared to Prior Yr >CASY

2025-12-09 21:36; UTC

Uždarbis

Casey's General Stores: Now Expects Inside Same-Store Sales to Increase 3% to 4% and an Inside Margin of 41% to 42% >CASY

2025-12-09 21:36; UTC

Uždarbis

Casey's General Stores: Same-Store Fuel Gallons Up 0.8% Compared to Prior Yr With Fuel Margin of 41.6 Cents per Gallon, Total Fuel Gross Profit Increased 20.9% to $377.4M Compared to Prior Yr >CASY

2025-12-09 21:36; UTC

Uždarbis

Casey's General Stores: Inside Same-Store Sales Increased 3.3% Compared to Prior Yr, and 7.5% on 2-Yr Stack Basis, With an Inside Margin of 42.4% >CASY

2025-12-09 20:28; UTC

Rinkos pokalbiai

Oil Futures Decline for Second Straight Session -- Market Talk

2025-12-09 20:27; UTC

Įsigijimai, susijungimai, perėmimai

Teck Resources: Merger of Equals With Anglo Amer Plc Approved by Both Classes of Teck Hldrs

2025-12-09 20:27; UTC

Įsigijimai, susijungimai, perėmimai

Teck Reports Voting Results From Special Meeting of Hldrs

2025-12-09 20:26; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Moody's: Paramount's Warner Bid Makes Strategic Sense, With Risk -- Market Talk

2025-12-09 20:21; UTC

Rinkos pokalbiai

U.S. Natural Gas Extends Pullback on Shifting Weather Outlook -- Market Talk

2025-12-09 19:52; UTC

Uždarbis

Correction to 58 S&P 500 Stocks Have Dividends Higher Than Treasuries. 10 Look Better Than Bonds. -- Barrons.com on Dec. 8

2025-12-09 19:17; UTC

Uždarbis

Update: 58 S&P 500 Stocks Have Dividends Higher Than Treasuries. 10 Look Better Than Bonds. -- Barrons.com

2025-12-09 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-09 17:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-12-09 17:11; UTC

Uždarbis

Nvidia Has Permission to Sell H200 Chips to China. Why It Might Not Matter Much for the Stock. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Pulse Biosciences Inc Prognozė

Kainos tikslas

By TipRanks

63.08% į viršų

12 mėnesių prognozė

Vidutinis 22 USD 63.08%

Aukščiausias 22 USD

Žemiausias 22 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Pulse Biosciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

Pirkti

Laikyti

Parduoti

Remiantis 1 analitikų, pateikusių Pulse Biosciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

16.59 / 17.17Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

Rinkos nuotaikos

By Acuity

134 / 374 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.